Case Report: Supplementing GSH Levels with Iontophoresis Patches

GSH patch box

Here at AgelessRx, we let science do the talking. That’s why we felt compelled to initiate our first scientific case report on glutathione supplementation and the Iontophoresis patches.

Our enthusiasm for sharing is two-fold. First, the study contains some vital and potentially groundbreaking research on glutathione supplementation as a safeguard against age-related disease. That said, we’d be remiss if not to also highlight the study’s author – AgelessRx Co-Founder and Chief Medical Officer, Dr. Sajad Zalzala.

In the report, Dr. Zalzala published his analysis of two distinct cases of low serum reduced glutathione in early September after three months of rigorous peer review. In the study, IontoPatch was used to replenish GSH in two individuals (a 73-year-old and a 67-year-old).

Glutathione (GSH) is the most prevalent exogenous antioxidant in human cells. It is also what is known as a tripeptide – a sort of power trio molecule containing three amino acid residues joined by peptide bonds.

We tend to run low on the ingredients needed to churn out GSH as we age or in response to high demand brought on by oxidative stress in the body. For instance, the antioxidant will deploy to fight elevated levels of free radicals that enter the blood through exposure to air pollutants and dangerous chemicals; or through diet, cigarette smoke, or alcohol consumption.

A decline in GSH concentrations results in decreased antioxidant activity in cells, which ultimately can lead to aging related illnesses. Conversely, padding the GSH coffers – say, through supplementation – has been linked to improved physical health as well as higher mental acuity.

In the cases documented in Dr. Zalzala’s report, physicians employed the IontoPatch for GSH supplementation, and with great success. After seven days of therapy, serum GSH levels rose (64.4 and 21.8 percent ). In each instance, no adverse effects were recorded.

To learn more about Glutathione, click here.

To read the full case report, click here.